Sevoflurane-Remifentanil Versus Propofol-Remifentanil Anesthesia During Noncardiac Surgery for Patients with Coronary Artery Disease – A Prospective Study Between 2016 and 2017 at a Single Center

21 August 2021 : Clinical Research

Zhongliang Dai^1ACDE, Miao Lin^1BDE, Yali Li^1BE, Wenli Gao^1BDE, Ping Wang^1BDE, Juan Lin^1CE, Zhenzhen Wan^2AE, Yuanxu Jiang^1CE*

DOI: 10.12659/MSM.929835

Med Sci Monit 2021; 27:e929835

Background Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Table 3 Secondary endpoints.

Variables	Sevoflurane (n=81)	Propofol (n=83)	P
Delirium, n (%)	36 (44.4)	35 (42.2)	0.797
PONV, n (%)	15 (18.5)	14 (16.9)	0.866
ICU Length-of-stay (hours)	13 (16.0)	14 (16.9)	0.642
In-hospital morbidity and mortality, n (%)	2 (2.5)	1 (1.2)	0.213
Length-of-stay in hospital (days)	8 (9.9)	9 (10.8)	0.356
PONV – postoperative nausea and vomiting; ICU – Intensive Care Unit.

Back to the Article